Cite
HARVARD Citation
Nestheide, S. et al. (n.d.). Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in ewing sarcoma. Pediatric blood & cancer. 60 (9), pp. 1437-1446. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nestheide, S. et al. (n.d.). Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in ewing sarcoma. Pediatric blood & cancer. 60 (9), pp. 1437-1446. [Online].